SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?

The Nurse Practitioner
Christy McDonald LenahanFrances Stueben

Abstract

Sodium-glucose cotransporter-2 (SGLT2) inhibitors can decrease risk for heart failure in patients with type 2 diabetes and can decrease risk of major cardiovascular events in patients with heart failure (HF) and diabetes. Specific SGLT2 inhibitors can also decrease major cardiovascular events in patients with HF only.

References

Oct 20, 2004·Circulation·James B YoungUNKNOWN Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees
Jan 3, 2015·Diabetes & Metabolism·S Halimi, B Vergès
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Mar 18, 2017·The Nurse Practitioner·Kathleen Broglio, Anne Walsh
May 21, 2017·The American Journal of Medicine·Michael Lehrke, Nikolaus Marx
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Aug 9, 2017·Cardiac Failure Review·Gianluigi Savarese, Lars H Lund
Oct 7, 2017·Journal of the American College of Cardiology·Dio KavalieratosRobert M Arnold
Nov 13, 2018·The New England Journal of Medicine·Stephen D WiviottUNKNOWN DECLARE–TIMI 58 Investigators
Dec 19, 2018·Circulation. Heart Failure·Sandra L JacksonMatthew D Ritchey
Jun 7, 2019·Circulation·Shannon M DunlayUNKNOWN American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Car
Jul 7, 2019·International Journal of Molecular Sciences·Álvaro García-RoperoJuan J Badimon
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Oct 15, 2019·Journal of the American Heart Association·Carolyn S P LamSubodh Verma
Mar 21, 2020·Journal of Diabetes Investigation·Ryuhei SanoTakeshi Ohta
Mar 29, 2020·Journal of the American College of Cardiology·Maya GuglinUNKNOWN ACC Heart Failure and Transplant Member Section and Leadership Council
Sep 1, 2020·The New England Journal of Medicine·Milton PackerUNKNOWN EMPEROR-Reduced Trial Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.